Oscar Health, Inc. (OSCR)
After hours:
Chart Events
Performance Outlook
| Previous Close | 4.5800 |
| Open | 4.6200 |
| Bid | 4.1000 x 2200 |
| Ask | 4.4800 x 4000 |
| Day's Range | 4.4050 - 4.7500 |
| 52 Week Range | 3.8900 - 22.5490 |
| Volume | |
| Avg. Volume | 1,964,925 |
| Market Cap | 932.651M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.6690 |
| Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.21 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for OSCR
Related Research
- Oscar Health, Inc.Daily – Vickers Top Buyers & Sellers for 09/20/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat9 months agoArgus Research
- Business Wire
Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual
NEW YORK, June 13, 2022--Oscar Health, Inc. ("Oscar") (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that on June 8, 2022 the Compensation Committee of Oscar’s Board of Directors approved the grant of inducement restricted stock unit awards covering 992,382 Class A shares of Oscar’s common stock to 29 new non-executive employees of Oscar and its affiliates to induce them to join Oscar and its affiliates. The awards were granted under Oscar’s
- Zacks
Is MetLife (MET) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Simply Wall St.
Investors in Oscar Health (NYSE:OSCR) from a year ago are still down 82%, even after 5.2% gain this past week
As every investor would know, you don't hit a homerun every time you swing. But serious investors should think long and...
